1-[5-(2-piperazin-1-ylethyl)-2,3-dihydroindol-1-yl]ethanone

CCOC(=O)c1cc2cccc(N3CCN(CCc4ccc5c(c4)CCN5C(C)=O)CC3)c2o1
Reaction #192
収率 61.5%750 AstraZeneca ELN dataset
CCOC(=O)c1cc2cccc(N3CCN(CCc4ccc5c(c4)CCN5C(C)=O)CC3)c2o1
Reaction #193
収率 64.4%750 AstraZeneca ELN dataset
CCOC(=O)c1cc2cccc(N3CCN(CCc4ccc5c(c4)CCN5C(C)=O)CC3)c2o1
Reaction #471004
product
収率 61.5%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_02
CCOC(=O)c1cc2cccc(N3CCN(CCc4ccc5c(c4)CCN5C(C)=O)CC3)c2o1
Reaction #622832
product
収率 61.5%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_10
CCOC(=O)c1cc2cccc(N3CCN(CCc4ccc5c(c4)CCN5C(C)=O)CC3)c2o1
Reaction #2429486
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (10/10)